|  | No postoperative complications | Postoperative complications | p value |
---|---|---|---|---|
Gender; n (%) | Female | 51 (50.0%) | 22 (36.7%) | 0.106 |
Male | 51 (50.0%) | 38 (63.3%) | ||
ASA; n (%) | I-II | 40 (40.8%) | 15 (26.8%) | 0.115 |
III-IV | 58 (59.2%) | 41 (73.2%) | ||
CCI; n (%) | ≤5 | 33 (32.4%) | 14 (23.3%) | 0.283 |
> 5 | 69 (67.6%) | 46 (76.7%) | ||
Ischemic heart disease; n (%) | Yes | 12 (11.8%) | 5 (8.3%) | 0.601 |
No | 90 (88.2%) | 55 (91.7%) | ||
Diabetes mellitus; n (%) | Yes | 16 (15.7%) | 8 (13.3%) | 0.820 |
No | 86 (84.3%) | 52 (86.7%) | ||
Cerebrovascular disease; n (%) | Yes | 7 (6.9%) | 2 (3.3%) | 0.487 |
No | 95 (93.1%) | 58 (96.7%) | ||
Chronic kidney failure; n (%) | Yes | 3 (2.9%) | 1 (1.7%) | 0.999 |
No | 99 (97.1%) | 59 (98.3%) | ||
Neoadjuvant treatment; n (%) | Yes | 19 (18.6%) | 10 (16.7%) | 0.834 |
No | 83 (81.4%) | 50 (83.3%) | ||
Tumor localization; n (%) | Rectum | 55 (53.9%) | 33 (55.0%) | 0.170 |
Rectosigmoid | 14 (13.7%) | 14 (23.3%) | ||
Sigmoid | 33 (32.4%) | 13 (21.7%) | ||
T; n (%) | T0–2 | 20 (19.6%) | 10 (16.7%) | 0.681 |
T3–4 | 82 (80.4%) | 50 (83.3%) | ||
M; n (%) | M0 | 92 (90.2%) | 52 (86.7%) | 0.606 |
M1 | 10 (9.8%) | 8 (13.3%) | ||
Stage; n (%) | 0 | 1 (1.0%) | 0 (0.0%) | 0.735 |
I | 13 (12.7%) | 10 (16.7%) | ||
II | 40 (39.2%) | 24 (40.0%) | ||
III | 38 (37.3%) | 18 (30.0%) | ||
IV | 10 (9.8%) | 8 (13.3%) | ||
Ligation of inferior mesenteric artery; n (%) | High | 71 (70.3%) | 42 (72.4%) | 0.857 |
Low | 30 (29.7%) | 16 (27.6%) | ||
Simultaneous operation; n (%) | Yes | 6 (5.9%) | 8 (13.3%) | 0.146 |
No | 96 (94.1%) | 52 (86.7%) | ||
Anastomosis level from anal verge; n (%) | ≤5 cm | 16 (19.8%) | 13 (26.5%) | 0.351 |
6–12 cm | 32 (39.5%) | 22 (44.9%) | ||
> 12 cm | 33 (40.7%) | 14 (28.6%) | ||
Approach of surgery; n (%) | Open | 52 (51.0%) | 41 (68.3%) | 0.034 |
Minimally invasive | 50 (49.0%) | 19 (31.7%) |